Reported aromatase serum concentrations for healthy controls range between 2.59 and 7.74 ng mL−1, and levels are significantly higher in the case of patients with bladder cancer (17.4–57.44 ng mL−1) [42]. The gene discussed is CYP19A1; the disease is urinary bladder carcinoma.